ATAD2 and cancer: We identified 15 BRD genes that may function as oncogenes in cancers, including BRD9, BRD4, and ATAD2. Excitingly, a number of inhibitors that target BRD4 have been developed42,43 and evaluated in multiple preclinical cancer models40,43–54.